@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP631757.RAFC2BGOjRUvWNAS49fk2DOSXPWS8EPLaf1tUlqAYtKgc130_head { this: np:hasAssertion dgn-np:NP631757.RAFC2BGOjRUvWNAS49fk2DOSXPWS8EPLaf1tUlqAYtKgc130_assertion; np:hasProvenance dgn-np:NP631757.RAFC2BGOjRUvWNAS49fk2DOSXPWS8EPLaf1tUlqAYtKgc130_provenance; np:hasPublicationInfo dgn-np:NP631757.RAFC2BGOjRUvWNAS49fk2DOSXPWS8EPLaf1tUlqAYtKgc130_publicationInfo; a np:Nanopublication . dgn-np:NP631757.RAFC2BGOjRUvWNAS49fk2DOSXPWS8EPLaf1tUlqAYtKgc130_assertion a np:Assertion . dgn-np:NP631757.RAFC2BGOjRUvWNAS49fk2DOSXPWS8EPLaf1tUlqAYtKgc130_provenance a np:Provenance . dgn-np:NP631757.RAFC2BGOjRUvWNAS49fk2DOSXPWS8EPLaf1tUlqAYtKgc130_publicationInfo a np:PublicationInfo . } dgn-np:NP631757.RAFC2BGOjRUvWNAS49fk2DOSXPWS8EPLaf1tUlqAYtKgc130_assertion { miriam-gene:5047 a ncit:C16612 . lld:C0524910 a ncit:C7057 . dgn-gda:DGN47da50b208e853ee00023a18fed074b1 sio:SIO_000628 miriam-gene:5047, lld:C0524910; a sio:SIO_001121 . } dgn-np:NP631757.RAFC2BGOjRUvWNAS49fk2DOSXPWS8EPLaf1tUlqAYtKgc130_provenance { dgn-np:NP631757.RAFC2BGOjRUvWNAS49fk2DOSXPWS8EPLaf1tUlqAYtKgc130_assertion dcterms:description "[This prospective, multicenter, community-based and academic-based, open-label, investigator-initiated, U.S. study evaluated efficacy and safety of pegylated interferon (PEG-IFN) alfa-2b plus a flat or weight-based dose of ribavirin (RBV) in adults with chronic hepatitis C. Patients (n = 5027) were randomly assigned to receive PEG-IFN alfa-2b 1.5 microg/kg/week plus flat-dose (800 mg/day) or weight-based (800-1400 mg/day) RBV for 48 weeks (patients with genotype 1, 4, 5, or 6) and for 24 or 48 weeks (genotype 2/3 patients).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:17894303; prov:wasDerivedFrom dgn-void:befree-2016; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-2016 pav:importedOn "2016-02-19"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP631757.RAFC2BGOjRUvWNAS49fk2DOSXPWS8EPLaf1tUlqAYtKgc130_publicationInfo { this: dcterms:created "2016-05-13T12:46:32+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v4.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v4.0.0" . }